MD Anderson And ARTIDIS Announce Strategic Alliance To Advance Nanomechanical Technology Platform For Optimizing Cancer Treatment
October 04, 2022
October 04, 2022
HOUSTON, Texas, Oct. 4 (TNSpar) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Oct. 3, 2022:
The University of Texas MD Anderson Cancer Center and ARTIDIS AG today announced a strategic alliance to investigate ARTIDIS technology as a novel treatment-optimization tool for patients with solid tumors in several distinct indications.
Supported by previous scientific evidence, the ARTIDIS atomic force microscopy (AFM) technol . . .
The University of Texas MD Anderson Cancer Center and ARTIDIS AG today announced a strategic alliance to investigate ARTIDIS technology as a novel treatment-optimization tool for patients with solid tumors in several distinct indications.
Supported by previous scientific evidence, the ARTIDIS atomic force microscopy (AFM) technol . . .